Biosimilars Market Size, Share & Trends Report

Biosimilars Market (2025 - 2033) Size, Share & Trends Analysis Report By Drug Class (Monoclonal Antibodies (mAbs), Growth Factors & Hematopoietic Agents), By Indication, By End Use, By Region, And Segment Forecasts

Market Segmentation

Biosimilars Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)
- Monoclonal Antibodies (mAbs)
- Growth Factors & Hematopoietic Agents
- Insulin & Analogues
- Osteoporosis / Bone Metabolism Agents
- Others
Biosimilars Indication Outlook (Revenue, USD Billion, 2021 - 2033)
- Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
- Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
- Diabetes Mellitus (Type 1 & Type 2)
- Ophthalmic Disorders (Wet AMD, DME, RVO)
- Hematologic / Rare Blood Disorders
- Others
Biosimilars End use Outlook (Revenue, USD Billion, 2021 - 2033)
- Hospitals
- Specialty Pharmacies
- Online & Retail Channels
Biosimilars Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
  - North America Biosimilars Market, By Drug Class
    - Monoclonal Antibodies (mAbs)
    - Growth Factors & Hematopoietic Agents
    - Insulin & Analogues
    - Osteoporosis / Bone Metabolism Agents
    - Others
  - North America Biosimilars Market, By Indication
    - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
    - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
    - Diabetes Mellitus (Type 1 & Type 2)
    - Ophthalmic Disorders (Wet AMD, DME, RVO)
    - Hematologic / Rare Blood Disorders
    - Others
  - North America Biosimilars Market, By End use
    - Hospitals
    - Specialty Pharmacies
    - Online & Retail Channels
  - U.S.
    - U.S. Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - U.S. Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - U.S. Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Canada
    - Canada Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Canada Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Canada Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Mexico
    - Mexico Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Mexico Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Mexico Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
- Europe
  - Europe Biosimilars Market, By Drug Class
    - Monoclonal Antibodies (mAbs)
    - Growth Factors & Hematopoietic Agents
    - Insulin & Analogues
    - Osteoporosis / Bone Metabolism Agents
    - Others
  - Europe Biosimilars Market, By Indication
    - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
    - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
    - Diabetes Mellitus (Type 1 & Type 2)
    - Ophthalmic Disorders (Wet AMD, DME, RVO)
    - Hematologic / Rare Blood Disorders
    - Others
  - Europe Biosimilars Market, By End use
    - Hospitals
    - Specialty Pharmacies
    - Online & Retail Channels
  - UK
    - UK Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - UK Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - UK Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Germany
    - Germany Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Germany Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Germany Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - France
    - France Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - France Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - France Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Italy
    - Italy Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Italy Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Italy Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Spain
    - Spain Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Spain Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Spain Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Denmark
    - Denmark Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Denmark Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Denmark Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Sweden
    - Sweden Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Sweden Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Sweden Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Norway
    - Norway Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Norway Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Norway Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
- Asia Pacific
  - Asia Pacific Biosimilars Market, By Drug Class
    - Monoclonal Antibodies (mAbs)
    - Growth Factors & Hematopoietic Agents
    - Insulin & Analogues
    - Osteoporosis / Bone Metabolism Agents
    - Others
  - Asia Pacific Biosimilars Market, By Indication
    - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
    - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
    - Diabetes Mellitus (Type 1 & Type 2)
    - Ophthalmic Disorders (Wet AMD, DME, RVO)
    - Hematologic / Rare Blood Disorders
    - Others
  - Asia Pacific Biosimilars Market, By End use
    - Hospitals
    - Specialty Pharmacies
    - Online & Retail Channels
  - Japan
    - Japan Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Japan Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Japan Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - China
    - China Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - China Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - China Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - India
    - India Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - India Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - India Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Australia
    - Australia Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Australia Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Australia Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - South Korea
    - South Korea Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - South Korea Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - South Korea Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Thailand
    - Thailand Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Thailand Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Thailand Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
- Latin America
  - Latin America Biosimilars Market, By Drug Class
    - Monoclonal Antibodies (mAbs)
    - Growth Factors & Hematopoietic Agents
    - Insulin & Analogues
    - Osteoporosis / Bone Metabolism Agents
    - Others
  - Latin America Biosimilars Market, By Indication
    - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
    - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
    - Diabetes Mellitus (Type 1 & Type 2)
    - Ophthalmic Disorders (Wet AMD, DME, RVO)
    - Hematologic / Rare Blood Disorders
    - Others
  - Latin America Biosimilars Market, By End use
    - Hospitals
    - Specialty Pharmacies
    - Online & Retail Channels
  - Brazil
    - Brazil Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Brazil Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Brazil Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Argentina
    - Argentina Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Argentina Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Argentina Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
- Middle East & Africa
  - Middle East & Africa Biosimilars Market, By Drug Class
    - Monoclonal Antibodies (mAbs)
    - Growth Factors & Hematopoietic Agents
    - Insulin & Analogues
    - Osteoporosis / Bone Metabolism Agents
    - Others
  - Middle East & Africa Biosimilars Market, By Indication
    - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
    - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
    - Diabetes Mellitus (Type 1 & Type 2)
    - Ophthalmic Disorders (Wet AMD, DME, RVO)
    - Hematologic / Rare Blood Disorders
    - Others
  - Middle East & Africa Biosimilars Market, By End use
    - Hospitals
    - Specialty Pharmacies
    - Online & Retail Channels
  - South Africa
    - South Africa Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - South Africa Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - South Africa Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Saudi Arabia
    - Saudi Arabia Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Saudi Arabia Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Saudi Arabia Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - UAE
    - UAE Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - UAE Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - UAE Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels
  - Kuwait
    - Kuwait Biosimilars Market, By Drug Class
      - Monoclonal Antibodies (mAbs)
      - Growth Factors & Hematopoietic Agents
      - Insulin & Analogues
      - Osteoporosis / Bone Metabolism Agents
      - Others
    - Kuwait Biosimilars Market, By Indication
      - Autoimmune Disorders (RA, IBD, Psoriasis, Ankylosing Spondylitis)
      - Oncology (Breast, Colorectal, Lymphoma, Lung, Gastric)
      - Diabetes Mellitus (Type 1 & Type 2)
      - Ophthalmic Disorders (Wet AMD, DME, RVO)
      - Hematologic / Rare Blood Disorders
      - Others
    - Kuwait Biosimilars Market, By End use
      - Hospitals
      - Specialty Pharmacies
      - Online & Retail Channels

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments